Skip to main content
Equibles

GW&K Investment Management, LLC

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1082917 BOSTON, MA
Back to AGIO Full portfolio

Position in AGIO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$44,777,482
+$3,677,382 QoQ
Shares Held
1,206,615
-0.7% QoQ
Ownership
2.02%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#16
of 238 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 96% Shared 4% None 0%

Common Shares in AGIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GW&K Investment Management, LLC holds $876,997,841 across 27 Biotechnology names. AGIO ranks #11 (5.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 1,353,883 $105,968,422
2 JAZZ
Jazz Pharmaceuticals plc
 350,667 $84,500,226
3 BBIO
BridgeBio Pharma, Inc.
 1,125,131 $83,799,756
4 CYTK
Cytokinetics Inc
 916,107 $78,043,155
5 LGND
Ligand Pharmaceuticals Inc
 246,883 $78,037,246
6 VCEL
Vericel Corp
 1,550,497 $68,981,610
7 INSM
INSMED Inc
 629,760 $67,145,010
8 CRNX
Crinetics Pharmaceuticals, Inc.
 1,731,140 $64,779,258

All Filings in AGIO

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $44,777,482 1,206,615
2026-03-31 $41,100,100 1,214,901
2025-12-31 $32,862,732 1,207,301
2025-09-30 $34,237,091 852,942
2025-06-30 $28,890,233 868,618
2025-03-31 $23,953,511 817,526
2024-12-31 $22,458,594 683,463
2024-09-30 $28,032,930 630,946
2024-06-30 $25,659,245 595,066
2024-03-31 $18,988,016 649,385